REPORT ID 710

Asia-Pacific Insomnia Therapy Market Report 2017

Publish Date
01-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the Asia-Pacific Insomnia Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Insomnia Therapy for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Insomnia Therapy market competition by top manufacturers/players, with Insomnia Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck & Co. Inc.
    Sanofi
    Pfizer, Inc.
    Takeda Pharmaceutical Company Ltd.
    Purdue Pharmaceuticals L.P.
    Eisai, Co. Ltd.
    Meda Consumer Healthcare Inc.
    Pernix Therapeutics
    Vanda Pharmaceuticals
    ECR Pharmaceuticals
    Fidia Farmaceutici
    Dainippon Sumitomo
    Biocodex
    Eli Lilly and Company
    Ebb Therapeutics

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Non-pharmacological Therapy
    Pharmacological Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Ambulatory Surgical Center
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Insomnia Therapy Market Report 2017
1 Insomnia Therapy Overview
    1.1 Product Overview and Scope of Insomnia Therapy
    1.2 Classification of Insomnia Therapy by Product Category
        1.2.1 Asia-Pacific Insomnia Therapy Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Insomnia Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Non-pharmacological Therapy
        1.2.4 Pharmacological Therapy
    1.3 Asia-Pacific Insomnia Therapy Market by Application/End Users
        1.3.1 Asia-Pacific Insomnia Therapy Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital
        1.3.3 Ambulatory Surgical Center
        1.3.4 Home Care
    1.4 Asia-Pacific Insomnia Therapy Market by Region
        1.4.1 Asia-Pacific Insomnia Therapy Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Insomnia Therapy (2012-2022)
        1.5.1 Asia-Pacific Insomnia Therapy Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Insomnia Therapy Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Insomnia Therapy Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Insomnia Therapy Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Insomnia Therapy Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Insomnia Therapy Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Insomnia Therapy (Volume and Value) by Type
        2.2.1 Asia-Pacific Insomnia Therapy Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Insomnia Therapy Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Insomnia Therapy (Volume) by Application
    2.4 Asia-Pacific Insomnia Therapy (Volume and Value) by Region
        2.4.1 Asia-Pacific Insomnia Therapy Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Insomnia Therapy Revenue and Market Share by Region (2012-2017)

3 China Insomnia Therapy (Volume, Value and Sales Price)
    3.1 China Insomnia Therapy Sales and Value (2012-2017)
        3.1.1 China Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Insomnia Therapy Revenue and Growth Rate (2012-2017)
        3.1.3 China Insomnia Therapy Sales Price Trend (2012-2017)
    3.2 China Insomnia Therapy Sales Volume and Market Share by Type
    3.3 China Insomnia Therapy Sales Volume and Market Share by Application

4 Japan Insomnia Therapy (Volume, Value and Sales Price)
    4.1 Japan Insomnia Therapy Sales and Value (2012-2017)
        4.1.1 Japan Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Insomnia Therapy Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Insomnia Therapy Sales Price Trend (2012-2017)
    4.2 Japan Insomnia Therapy Sales Volume and Market Share by Type
    4.3 Japan Insomnia Therapy Sales Volume and Market Share by Application

5 South Korea Insomnia Therapy (Volume, Value and Sales Price)
    5.1 South Korea Insomnia Therapy Sales and Value (2012-2017)
        5.1.1 South Korea Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Insomnia Therapy Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Insomnia Therapy Sales Price Trend (2012-2017)
    5.2 South Korea Insomnia Therapy Sales Volume and Market Share by Type
    5.3 South Korea Insomnia Therapy Sales Volume and Market Share by Application

6 Taiwan Insomnia Therapy (Volume, Value and Sales Price)
    6.1 Taiwan Insomnia Therapy Sales and Value (2012-2017)
        6.1.1 Taiwan Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Insomnia Therapy Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Insomnia Therapy Sales Price Trend (2012-2017)
    6.2 Taiwan Insomnia Therapy Sales Volume and Market Share by Type
    6.3 Taiwan Insomnia Therapy Sales Volume and Market Share by Application

7 India Insomnia Therapy (Volume, Value and Sales Price)
    7.1 India Insomnia Therapy Sales and Value (2012-2017)
        7.1.1 India Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Insomnia Therapy Revenue and Growth Rate (2012-2017)
        7.1.3 India Insomnia Therapy Sales Price Trend (2012-2017)
    7.2 India Insomnia Therapy Sales Volume and Market Share by Type
    7.3 India Insomnia Therapy Sales Volume and Market Share by Application

8 Southeast Asia Insomnia Therapy (Volume, Value and Sales Price)
    8.1 Southeast Asia Insomnia Therapy Sales and Value (2012-2017)
        8.1.1 Southeast Asia Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Insomnia Therapy Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Insomnia Therapy Sales Price Trend (2012-2017)
    8.2 Southeast Asia Insomnia Therapy Sales Volume and Market Share by Type
    8.3 Southeast Asia Insomnia Therapy Sales Volume and Market Share by Application

9 Australia Insomnia Therapy (Volume, Value and Sales Price)
    9.1 Australia Insomnia Therapy Sales and Value (2012-2017)
        9.1.1 Australia Insomnia Therapy Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Insomnia Therapy Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Insomnia Therapy Sales Price Trend (2012-2017)
    9.2 Australia Insomnia Therapy Sales Volume and Market Share by Type
    9.3 Australia Insomnia Therapy Sales Volume and Market Share by Application

10 Asia-Pacific Insomnia Therapy Players/Suppliers Profiles and Sales Data
    10.1 Merck & Co. Inc.
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Insomnia Therapy Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Merck & Co. Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Sanofi
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Insomnia Therapy Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Sanofi Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Pfizer, Inc.
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Insomnia Therapy Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Pfizer, Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Takeda Pharmaceutical Company Ltd.
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Insomnia Therapy Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Purdue Pharmaceuticals L.P.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Insomnia Therapy Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Eisai, Co. Ltd.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Insomnia Therapy Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Eisai, Co. Ltd. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Meda Consumer Healthcare Inc.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Insomnia Therapy Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Pernix Therapeutics
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Insomnia Therapy Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Pernix Therapeutics Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Vanda Pharmaceuticals
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Insomnia Therapy Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Vanda Pharmaceuticals Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 ECR Pharmaceuticals
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Insomnia Therapy Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 ECR Pharmaceuticals Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Fidia Farmaceutici
    10.12 Dainippon Sumitomo
    10.13 Biocodex
    10.14 Eli Lilly and Company
    10.15 Ebb Therapeutics

11 Insomnia Therapy Manufacturing Cost Analysis
    11.1 Insomnia Therapy Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Insomnia Therapy

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Insomnia Therapy Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Insomnia Therapy Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Insomnia Therapy Market Forecast (2017-2022)
    15.1 Asia-Pacific Insomnia Therapy Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Insomnia Therapy Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Insomnia Therapy Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Insomnia Therapy Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Insomnia Therapy Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Insomnia Therapy Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Insomnia Therapy Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Insomnia Therapy Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Insomnia Therapy Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Insomnia Therapy Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Insomnia Therapy Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Insomnia Therapy Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer